Successful Treatment of Fulminant <i>Clostridium difficile</i> Infection with Fecal Bacteriotherapy
Authors: David M. You, M. Alaric Franzos, Robert P. Holman
Journal: Annals of Internal Medicine (2008)

Letters15 April 2008Successful Treatment of Fulminant Clostridium difficile Infection with Fecal BacteriotherapyDavid M. You, MD, M. Alaric Franzos, MD, and Robert P. Holman, MDDavid M. You, MDFrom National Naval Medical Center, Bethesda, MD 20889, and Virginia Hospital Center, Arlington, VA 22205., M. Alaric Franzos, MDFrom National Naval Medical Center, Bethesda, MD 20889, and Virginia Hospital Center, Arlington, VA 22205., and Robert P. Holman, MDFrom National Naval Medical Center, Bethesda, MD 20889, and Virginia Hospital Center, Arlington, VA 22205.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-148-8-200804150-00024 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Background: A subset of patients with Clostridium difficile–associated diarrhea will develop fulminant, life-threatening C. difficile infection that is refractory to medical therapy. Surgical options for fulminant disease are associated with high mortality rates. We describe a patient with fulminant C. difficile infection successfully treated with donor stool by retention enema.Objective: To describe a successful case of using fecal bacteriotherapy to treat life-threatening, fulminant C. difficile enterocolitis.Case Report: A 69-year-old man was admitted to the hospital after undergoing radical prostatectomy. The patient was given perioperative, intravenous cefazolin. On postoperative day 2, the patient developed an ileus and oliguric renal ...References1. Dallal RM, Harbrecht BG, Boujoukas AJ, Sirio CA, Farkas LM, Lee KK, et al. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg. 2002;235:363-72. [PMID: 11882758] CrossrefMedlineGoogle Scholar2. Koss K, Clark MA, Sanders DS, Morton D, Keighley MR, Goh J. The outcome of surgery in fulminant Clostridium difficile colitis. Colorectal Dis. 2006;8:149-54. [PMID: 16412077] CrossrefMedlineGoogle Scholar3. Aas J, Gessert CE, Bakken JS. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis. 2003;36:580-5. [PMID: 12594638] CrossrefMedlineGoogle Scholar4. Persky SE, Brandt LJ. Treatment of recurrent Clostridium difficile-associated diarrhea by administration of donated stool directly through a colonoscope. Am J Gastroenterol. 2000;95:3283-5. [PMID: 11095355] MedlineGoogle Scholar5. Tvede M, Rask-Madsen J. Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients. Lancet. 1989;1:1156-60. [PMID: 2566734] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: From National Naval Medical Center, Bethesda, MD 20889, and Virginia Hospital Center, Arlington, VA 22205.Disclaimer: The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the U.S. Department of the Navy, U.S. Department of Defense, or the U.S. government.Disclosures: None disclosed. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByFecal Microbial Transplantation in Critically Ill Patients—Structured Review and PerspectivesExploring Human Bacterial Diversity Toward Prevention of Infectious Disease and Health PromotionTrasplante de microbiota fecal en el tratamiento de colitis grave complicada por C. difficile en un paciente con síndrome de inmunodeficiencia adquiridaFecal microbiota transplantation for severe complicated C. difficile colitis in a patient with acquired immunodeficiency syndromeSafety and efficacy of encapsulated fecal microbiota transplantation for recurrent Clostridium difficile infection: a systematic reviewResearch Agenda for Microbiome Based Research for Multidrug-resistant Organism Prevention in the Veterans Health Administration SystemControl of Clostridium difficile Infection by Defined Microbial CommunitiesIntestinal-Based Diseases and Peripheral Infection Risk Associated with Gut Dysbiosis: Therapeutic use of Pre- and Probiotics and Fecal Microbiota TransplantationControl of Clostridium difficile Infection by Defined Microbial CommunitiesFecal microbiota transplant in severe and severe-complicated Clostridium difficile : A promising treatment approachCurrent challenges in the treatment of severe Clostridium difficile infection: early treatment potential of fecal microbiota transplantationFMT in Clostridium difficile and Other Potential UsesFecal microbiota transplant in patients with Clostridium difficile infectionFecal Microbiota TransplantElevated fecal calprotectin associates with adverse outcomes from Clostridium difficile infection in older adultsEpidemiology, Diagnosis, and Management of Clostridium difficile Infection in Patients with Inflammatory Bowel DiseaseLong-term Follow-up Study of Fecal Microbiota Transplantation for Severe and/or Complicated Clostridium difficile InfectionFecal Transplant for Treatment of Toxic Megacolon Associated With Clostridium Difficile Colitis in a Patient With Duchenne Muscular DystrophyAdverse events in faecal microbiota transplant: a review of the literatureFecal microbiota transplantation for the treatment of Clostridium difficile infectionInteractions between the intestinal microbiome and helminth parasitesEffectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium difficile infectionFecal microbiota transplantation in gastrointestinal disease: 2015 update and the road aheadLeaping Forward in the Treatment of Clostridium Difficile Infection: Update in 2015Recurrent Clostridium difficile infection: From colonization to cureFaecal microbiota transplantation plus selected use of vancomycin for severe-complicated Clostridium difficile infection: description of a protocol with high success rateUpdate on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and OutlookTrasplante de microbiota fecalFecal Microbiota Transplantation for the Management of Clostridium difficile InfectionA different kind of "allogeneic transplant": successful fecal microbiota transplant for recurrent and refractory Clostridium difficile infection in a patient with relapsed aggressive B-cell lymphomaTreatment of Recurrent and Severe Clostridium Difficile InfectionIntestinal Microbiota Transplantation, a Simple and Effective Treatment for Severe and Refractory Clostridium Difficile InfectionRecent Update in Fecal Microbiota TransplantationEmergence of fecal microbiota transplantation as an approach to repair disrupted microbial gut ecologyFecal microbiota transplantation for Clostridium difficile infection: A surgeon׳s perspectiveFecal Microbiota Transplantation for the Treatment of Clostridium difficile InfectionClostridium Difficile ColitisFecal microbiota transplantation for management of Clostridium difficile infectionSystematic review: faecal microbiota transplantation therapy for digestive and nondigestive disorders in adults and childrenManipulation of the Host-Cell Pathways by Bacterial EnteropathogensA Mathematical Model to Evaluate the Routine Use of Fecal Microbiota Transplantation to Prevent Incident and Recurrent Clostridium difficile InfectionFecal microbiota transplantationCould fecal microbiota transplantation cure all Clostridium difficile infections?Moving Fecal Microbiota Transplantation Into the MainstreamAlteration of the intestinal microbiome: fecal microbiota transplant and probiotics for Clostridium difficile and beyondAn overview of fecal microbiota transplantation: techniques, indications, and outcomesPhysician Attitudes Toward the Use of Fecal Transplantation for Recurrent Clostridium difficile Infection in a Metropolitan AreaRelationship of symptom duration and fecal bacteriotherapy in Clostridium difficile infection-pooled data analysis and a systematic reviewFaecal microbiota transplantation for severe clostridium difficile infection in the intensive care unitDuodenal Infusion of Donor Feces for Recurrent Clostridium difficileFecal microbiota transplantationDetailed methodological recommendations for the treatment of Clostridium difficile-associated diarrhea with faecal transplantationEarly Development of Intestinal MicrobiotaFecal Microbiota TransplantationFecal microbiota transplantation for fulminant Clostridium difficile infection in an allogeneic stem cell transplant patientFecal microbiota transplantation in relapsing Clostridium difficile infectionNovel Management Strategies in the Treatment of Severe Clostridium difficile InfectionMycobacterium avium ss paratuberculosis-associated DiseasesDefining the human microbiomeDetection, Treatment, and Prevention of Clostridium difficile InfectionFecal Transplantation, Through Colonoscopy, Is Effective Therapy for Recurrent Clostridium difficile InfectionAgeing of the human metaorganism: the microbial counterpartFecal microbiota transplantation and emerging applicationsFecal Microbiota Transplantation for Relapsing Clostridium difficile Infection in 26 PatientsClinical approach to severe Clostridium difficile infection: Update for the hospital practitionerSystematic Review of Intestinal Microbiota Transplantation (Fecal Bacteriotherapy) for Recurrent Clostridium difficile InfectionFecal Microbiota Transplantation for Recurrent Clostridium difficile InfectionReview article: faecal transplantation therapy for gastrointestinal diseaseTreatment of refractory and recurrent Clostridium difficile infectionUnravelling the effects of the environment and host genotype on the gut microbiomeThe Ecology and Pathobiology of Clostridium difficile Infections: An Interdisciplinary ChallengeAlternative Therapies for Clostridium difficile InfectionsAn Update on Clostridium difficile Infection and its ManagementFecal Flora Reconstitution for Recurrent Clostridium difficile Infection: Results and MethodologyFecal Bacteriotherapy, Fecal Transplant, and the MicrobiomeClostridium difficileGas Gangrene and Other Clostridium-Associated DiseasesAntibiotic-Associated Diarrhea, Pseudomembranous Enterocolitis, and Clostridium difficile-Associated Diarrhea and ColitisAntibiotics-associated Diarrhea and Other Gastrointestinal Abnormal Responses Regarding Helicobacter pylori EradicationA 69-Year-Old Woman Presenting to the Hospital With 48 Hours of Abdominal Pain and DiarrheaTreatment of Clostridium difficile-Associated DiseaseThe First Case of Antibiotic-associated Colitis by Clostridium difficile PCR Ribotype 027 in KoreaClostridium diffcile associated infection, diarrhea andcolitisManagement of Antibiotics-Associated Diarrhea 15 April 2008Volume 148, Issue 8Page: 632-633KeywordsBlood pressureCase seriesDeath ratesDiarrheaHemofiltrationHypotensionPatientsVancomycinVasopressors ePublished: 15 April 2008 Issue Published: 15 April 2008 CopyrightCopyright © 2008 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...